Opinions
Bruce Sellery
Medmira Inc
MIR-X
BUY
Oct 30, 2000
Getting global acceptance of products. Low volume
$3.000
Stock price when the opinion was issued
biotechnology
pharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
TOP PICK
In Canada, this smallcap (C$210 million) biotech in Halifax submitted its antibody test to the FDA. Since April 22, MedMira has soared from 6 cents/share to over 30. There's scant coverage or even stock metrics to report. Also MedMira is one of many companies to submit such tests to the FDA, but it's worth keeping on your radar. At this stage of pandemic, I wouldn't rule out any stock that could effectively fight the virus.
biotechnology
pharmaceutical
Advertising